Medtronic will enter into the next phase of its strategic partnership with Mazor Robotics, making a third investment in the company.
Medtronic CEO Omar Ishrak received $15.7 million in compensation for the 2017 fiscal year.
InVivo Therapeutics eliminated 13 positions in a quest to focus attention on the Inspire Study and earn an FDA humanitarian device exemption for the Neuro-Spinal Scaffold.
NuVasive plans to expand its San Diego-based headquarters and add an innovation center to the facility.
MicroPort Orthopedics launched its Procotyl Prime Acetabular Cup System for hip replacement surgery.
Anika Therapeutics, a global orthopedic medicines company, elected Steven Chartier to vice president of regulatory and clinical affairs.
More articles on devices:
Spine implant segment leads global orthopedic device market: 6 observations
6 key quotes from CEO Omar Ishrak during Medtronic’s Q1 earnings call
20 spine devices receive FDA 510(k) clearances in July
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
